Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 4
1973 2
1974 2
1979 2
1984 1
1987 1
1988 2
1989 1
1990 6
1991 9
1992 11
1993 12
1994 35
1995 26
1996 53
1997 70
1998 84
1999 110
2000 153
2001 185
2002 258
2003 272
2004 315
2005 342
2006 403
2007 376
2008 345
2009 373
2010 449
2011 415
2012 388
2013 422
2014 359
2015 367
2016 323
2017 305
2018 277
2019 201
2020 19
Text availability
Article attribute
Article type
Publication date

Search Results

6,243 results
Results by year
Filters applied: . Clear all
Page 1
Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee.
Compostella A, Affinita MC, Casanova M, Milano GM, Scagnellato A, Dall'Igna P, Chiaravalli S, Pierobon M, Manzitti C, Zanetti I, Schiavetti A, Sorbara S, Mura RM, Ruggiero A, Ferrari A, Bisogno G. Compostella A, et al. Tumori. 2019 Apr;105(2):138-143. doi: 10.1177/0300891618792479. Epub 2018 Aug 22. Tumori. 2019. PMID: 30131003 Clinical Trial.
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
Sanoff HK, Goldberg RM, Ivanova A, O'Reilly S, Kasbari SS, Kim RD, McDermott R, Moore DT, Zamboni W, Grogan W, Cohn AL, Bekaii-Saab TS, Leonard G, Ryan T, Olowokure OO, Fernando NH, McCaffrey J, El-Rayes BF, Horgan AM, Sherrill GB, Yacoub GH, O'Neil BH. Sanoff HK, et al. Cancer. 2018 Aug 1;124(15):3118-3126. doi: 10.1002/cncr.31552. Epub 2018 Jun 15. Cancer. 2018. PMID: 29905927 Free article. Clinical Trial.
Alternative administration of camptothecin analogues.
Glaberman U, Rabinowitz I, Verschraegen CF. Glaberman U, et al. Expert Opin Drug Deliv. 2005 Mar;2(2):323-33. doi: 10.1517/17425247.2.2.323. Expert Opin Drug Deliv. 2005. PMID: 16296757 Review.
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.
Hol JA, van den Heuvel-Eibrink MM, Graf N, Pritchard-Jones K, Brok J, van Tinteren H, Howell L, Verschuur A, Bergeron C, Kager L, Catania S, Spreafico F, Mavinkurve-Groothuis AMC. Hol JA, et al. Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26849. Epub 2017 Oct 27. Pediatr Blood Cancer. 2018. PMID: 29077255 Clinical Trial.
Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer.
Leonard SC, Lee H, Gaddy DF, Klinz SG, Paz N, Kalra AV, Drummond DC, Chan DC, Bunn PA, Fitzgerald JB, Hendriks BS. Leonard SC, et al. Anticancer Drugs. 2017 Nov;28(10):1086-1096. doi: 10.1097/CAD.0000000000000545. Anticancer Drugs. 2017. PMID: 28857767
Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
Goto K, Ohe Y, Shibata T, Seto T, Takahashi T, Nakagawa K, Tanaka H, Takeda K, Nishio M, Mori K, Satouchi M, Hida T, Yoshimura N, Kozuki T, Imamura F, Kiura K, Okamoto H, Sawa T, Tamura T; JCOG0605 investigators. Goto K, et al. Lancet Oncol. 2016 Aug;17(8):1147-1157. doi: 10.1016/S1470-2045(16)30104-8. Epub 2016 Jun 14. Lancet Oncol. 2016. PMID: 27312053 Clinical Trial.
Alternative administration of camptothecin analogues.
Verschraegen CF, Jaeckle K, Giovanella B, Knight V, Gilbert BE. Verschraegen CF, et al. Ann N Y Acad Sci. 2000;922:237-46. doi: 10.1111/j.1749-6632.2000.tb07042.x. Ann N Y Acad Sci. 2000. PMID: 11193899 Review.
6,243 results
Jump to page
Feedback